ACOG (Alpha Cognition) 6-Month Price Index: 1.64 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACOG Alpha Cognition Inc ACOG
35 GF Score
Price $8.92
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition 6-Month Price Index?

Alpha Cognition ACOG +6.70% 35 6-Month Price Index is 1.64 as of Aug. 04, 2026. GuruFocus rates ACOG with a GF Score™ of 35/100. The stock has 3 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-08-04), Alpha Cognition's 6-Month Price Index is 1.64.

Alpha Cognition  (NAS:ACOG) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Alpha Cognition 6-Month Price Index Related Terms

ACOG vs MENS, NGEN, LENZ: 6-Month Price Index Comparison

For the Biotechnology subindustry, Alpha Cognition's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ACOG
35GF Score
Alpha Cognition Inc ACOG
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition  (NAS:ACOG) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.64 mean?
Alpha Cognition (ACOG) has a 6-Month Price Index of 1.64 as of Aug. 04, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Alpha Cognition and its competitors.
Is Alpha Cognition's 6-Month Price Index too high?
Alpha Cognition's current 6-Month Price Index is 1.64. Overall, Alpha Cognition has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's 6-Month Price Index compare to MENS and NGEN?
Alpha Cognition's 6-Month Price Index of 1.64 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Biotechnology company?
A good 6-Month Price Index depends on the Biotechnology industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Alpha Cognition and its competitors. Alpha Cognition's current 6-Month Price Index is 1.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current 6-Month Price Index of 1.64. The current 6-Month Price Index is 1.64. Alpha Cognition's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current 6-Month Price Index is 1.64 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
35GF Score

Get the complete analysis for ACOG

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.92
Price